Uptake of the childhood live attenuated influenza vaccine (LAIV) and influenza-related healthcare resource use in England during the 2012 to 2022 flu seasons; a retrospective, observational study in the CPRD and HES databases

Trial Identifier:	D2560R00011
Sponsor:	AstraZeneca
Start Date:	January 2023
Primary Completion Date:	July 2023
Study Completion Date:	July 2023
Condition:	Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
England	London, England

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.